论文信息 - Angiotensin II infusion in COVID-19-associated vasodilatory shock: a case series - 字舞流文

Angiotensin II infusion in COVID-19-associated vasodilatory shock: a case series

R. Bellomo | A. Zangrillo | A. Scandroglio | L. Dagna | A. Serpa Neto | G. Landoni | M. Tresoldi | F. Ciceri | M. Azzolini | L. Beretta | P. Scarpellini | A. Dell'Acqua | E. Fominskiy | G. Monti | G. Valsecchi | P. Silvani | Federica Morselli | Yanase Fumitaka | O. Saleh | Gaetano Lombardi | S. Colombo | Antonio Bellantoni | Anna Mara Sergio Antonio Paolo Evgeny Giacomo Maria Lui Scandroglio Colombo Dell’Acqua Silvani Fomin | Cristina Barberio | Omar A. Saleh

[1] A. Khanna,et al. COVID-19 and the RAAS—a potential role for angiotensin II? , 2020, Critical Care.

[2] A. Verma,et al. COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence? , 2020, JAMA.

[3] Sharukh Lokhandwala,et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. , 2020, JAMA.

[4] R. Bellomo,et al. Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock , 2020, Critical Care.

[5] R. Bellomo,et al. Angiotensin II for the Treatment of Vasodilatory Shock , 2017, The New England journal of medicine.

[6] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..